Long-term follow-up results of the ZUMA-1 trial of anti-CD19 CAR T-cells for non-Hodgkin lymphoma

The latest CAR T-cell data was highly anticipated at the American Society of Hematology (ASH) 2017 Annual Meeting and Exposition in Atlanta, GA. Speaking from the meeting, Sattva Neelapu, MD, from the... Author: VJHemOnc Added: 01/05/2018
Source: Oncology Tube - Category: Cancer & Oncology Source Type: podcasts